HTG Molecular Diagnostics, Inc. (HTGMQ)
OTCMKTS: HTGMQ · Delayed Price · USD
0.0015
0.00 (0.00%)
Apr 15, 2024, 12:33 PM EDT - Market open
HTG Molecular Diagnostics Market Cap
HTG Molecular Diagnostics has a market cap or net worth of $3.32 thousand as of April 16, 2024. Its market cap has decreased by -99.92% in one year.
Market Cap
3.32K
Enterprise Value
n/a
1-Year Change
-99.92%
Ranking
n/a
Category
Stock Price
$0.00
Market Cap Chart
Since May 6, 2015, HTG Molecular Diagnostics's market cap has decreased from $92.70M to $3.32K, a decrease of -100.00%. That is a compound annual growth rate of -71.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 14, 2023 | 1.10M | -15.38% |
| Jun 13, 2023 | 1.30M | - |
| Jun 12, 2023 | 1.30M | -18.75% |
| Jun 9, 2023 | 1.60M | -15.79% |
| Jun 8, 2023 | 1.90M | 11.76% |
| Jun 7, 2023 | 1.70M | -10.53% |
| Jun 6, 2023 | 1.90M | -48.65% |
| Jun 5, 2023 | 3.70M | -21.28% |
| Jun 2, 2023 | 4.70M | -2.08% |
| Jun 1, 2023 | 4.80M | - |
| May 31, 2023 | 4.80M | 6.67% |
| May 30, 2023 | 4.50M | - |
| May 26, 2023 | 4.50M | -11.76% |
| May 25, 2023 | 5.10M | -8.93% |
| May 24, 2023 | 5.60M | -8.20% |
| May 23, 2023 | 6.10M | -1.61% |
| May 22, 2023 | 6.20M | 3.33% |
| May 19, 2023 | 6.00M | - |
| May 18, 2023 | 6.00M | -3.23% |
| May 17, 2023 | 6.20M | 8.77% |
| May 16, 2023 | 5.70M | -1.72% |
| May 15, 2023 | 5.80M | -3.33% |
| May 12, 2023 | 6.00M | 3.45% |
| May 11, 2023 | 5.80M | -1.69% |
| May 10, 2023 | 5.90M | 9.26% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 714.63B |
| Novo Nordisk | 555.41B |
| UnitedHealth Group | 404.91B |
| Johnson & Johnson | 355.34B |
| Merck & Co. | 318.45B |
| AbbVie | 287.34B |
| Thermo Fisher | 215.76B |
| AstraZeneca | 213.67B |